Evidence map›Paper›PMID 27621573›Full record

ReviewWorld journal of gastroenterology2016

Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Maria Inge Lusida, Juniastuti, Yoshihiko Yano

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The changing epidemiology of liver diseases in the Asia-Pacific region.Nature reviews. Gastroenterology & hepatology · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Maria Inge LusidaMaria Inge Lusida, Juniastuti, Institute of Tropical Disease, Airlangga Health Science Institute, Airlangga University, Surabaya 60115, East Java, Indonesia.
JuniastutiMaria Inge Lusida, Juniastuti, Institute of Tropical Disease, Airlangga Health Science Institute, Airlangga University, Surabaya 60115, East Java, Indonesia.
Yoshihiko YanoMaria Inge Lusida, Juniastuti, Institute of Tropical Disease, Airlangga Health Science Institute, Airlangga University, Surabaya 60115, East Java, Indonesia.
Airlangga University · IDCreative Research Enterprises (United States) · USKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indonesia has a moderate to high endemicity of hepatitis B virus (HBV) infection. The risk for chronic HBV infection is highest among those infected during infancy. Since 1997, hepatitis B (HepB) vaccination of newborns has been fully integrated into the National Immunization Program. Although HBV infection has been reduced by the universal newborn HepB immunization program, it continues to occur in Indonesia. The low birth dose coverage and the presence of vaccine escape mutants might contribute to this endemicity among children. Although limited information is available for an analysis of occult HBV infection (OBI), several variations and substitutions in the pre-S/S region have been detected in Indonesian HBV strains. Additionally, persistent infection and disease progression of chronic hepatitis B are related to not only viral factors but also the host genome. Indonesia is one of the most ethnically heterogeneous nations, with Javanese and Sundanese as the two highest ethnic groups. This multi-ethnicity makes genomic research in Indonesia difficult. In this article, we focused on and reviewed the following aspects: the current hepatitis B immunization program and its efficacy, OBI, HBV infection among high-risk patients, such as hemodialysis patients, and research regarding the host genome in Indonesia.

Indexed as

FemaleGenetic VariationHepatitis B, ChronicHepatitis B VaccinesHepatitis B virusHLA AntigensHost-Pathogen InteractionsHumansIndonesiaMalePregnancyRenal DialysisRisk FactorsHepatitis B VaccinesHLA AntigensHemodialysisHepatitis B virusImmunizationIndonesiaOccult infection

Identifiers

PMID27621573
PMCPMC4997646
OpenAlexW2516201002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.